|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | BEL-1,A novel clavulanic acid-inhibited extended-spectrum β-lactamase and the class 1 integron In120 in Pseudomonas aeruginosa显示文摘 | Poirel L Brinas L Verlinde A | 2005 | Antimicrob Agents Chemother2005，49，9： | 1 |
| 2 | Se- lective inhibition o{ trypanosomal glyceraldehyde-3- phosphate dehydrogenase by protein structure-based design:Toward new drugs for the treatment of sleep- ing sickness显示文摘 | Verlinde C L Callens M Van calenbergl S | 1994 | Medicinal Chemistry1994，37，36： | 1 |
| 3 | 5 - fluorouracil/ leucovorincombined with irinotecan and oxaliplatin (FOLFIRINOX) as second -linechemotherapy in patients with metastatic pancreatic adeno- carcinoma显示文摘 | Assaf E Verlinde - Carvaibo M Delbaido C | 2011 | Oncology2011，80，5： | 1 |
| 4 | Waveletdecomposition analysis of heart ratevariability in aerobic athletes显示文摘 | Dieter Beckers etal | 2001 | Autonomic Neuroscience2001，90，7： | 1 |
| 5 | BEL-1, a novel clavulanic acid-inhibited extended-spectrum β-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa显示文摘 | Poirel L Brinas L Verlinde A | 2005 | Antimicrob Agents Chemother2005，49，9： | 1 |
| 6 | BEL-1, a novel elavulanic acid-inhibited extend spectrum laetamase, and the class 1 integron In120 in Pseudomas aeruginosa显示文摘 | Poirel L Brinas L Verlinde A | 2005 | Antimicrob Agents Chemother2005，49，10： | 1 |
| 7 | BEL-1, a Novel Clavulanic Acid-Inhibited Extended-Spectrum B-Lactamase, and the Class 1 Integron In120 in Pseudomonas aeruginosa显示文摘 | Poirel L Brinas L Verlinde A | 2005 | Antimicrob Agents Chemother2005，49，9： | 1 |
| 8 | Cloud droplet size distributions in low-level stratiform clouds显示文摘 | Miles N Verlinde L and Clothiaux E E | 2000 | J Atmos Sci2000，57，2： | 1 |
| 9 | Can symtomsdiscriminate among those with deLayed or normalgastric emptying in dysmotiliy - like dyspepsia 显示文摘 | Talley N J Verlindent M Jones H | 2001 | AmJ Gastroenterol2001，96，5： | 1 |
| 10 | A deletion hybrid breakpoint map of the chromosomal region13q14-q21 orders 19 genetic markers in 10 intervals显示文摘 | KOOY RF VERLIND E HOUWEN RH | 1994 | Eur J Hum Genet1994，2，1： | 1 |
| 11 | Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodie eerebellar ataxia显示文摘 | Chen DH Brkanac Z Verlinde CL | 2003 | Am J Hum Genet2003，72，4： | 1 |
| 12 | BEL-1, A novel clavulanic acid inhibited extended spectrum β-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa 显示文摘 | Poirel L Brinas L Verlinde A | 2005 | Antimicrob Agents Chemother2005，49，9： | 1 |
| 13 | How to Consolidate Urban Flows of Goods Without Setting up an Urban Consolidation Centre?显示文摘 | Sara Verlinde Cathy Macharis Frank Witlox | 2012 | Procedia - Social and Behavioral Sciences2012，，： | 1 |
| 14 | Maternal hyper-homocysteinaemia is a risk factor for congenital heart disease显示文摘 | Verkleij-Hagoort A C Verlinde M Ursem N T | 2006 | BJOG2006，113，12： | 1 |
| 15 | Cloud droplet size distributions in low-level stratiform clouds显示文摘 | Miles N L Verlinde J Clothiaux E E | 2000 | J Atmos Sci2000，57，2： | 1 |
| 16 | Can symptoms discriminate among those with delayed or nomal gastric emptying in dysmitility-like dyspepsia显示文摘 | TALLEY N J VERLINDER M JONES H | 2001 | Am J Gastroenterol2001，96，5： | 1 |
| 17 | BEL-I, a Novel Clavulanic Acid-Inhibited Extended-Spectrum B-Lactamase, and the Class 1 Integron In120 in Pseudomonas aeruginosa显示文摘 | Poirel L Brinas L Verlinde A | 2005 | Antimicrob Agents Chemother2005，49，9： | 1 |
| 18 | Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia显示文摘 | Brkanac Z Verlinde CL | 2003 | Am J Hum Genet2003，72，4： | 1 |
| 19 | Thesocial gradient in doctor-patient communication 显示文摘 | Verlinde E De Laender N De Maesschalck S | 2012 | Int JEquity Health2012，11，： | 1 |
| 20 | Can symptomsdiscriminate among those with delayed or nom al gastricemptying in dysmitility-like dys- pepsia显示文摘 | Talley N J Verlinder M Jones H | 2001 | Am J Gastroentero12001，96，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员